Pacira Biosciences
PCRX
#5836
Rank
S$1.39 B
Marketcap
S$31.09
Share price
0.04%
Change (1 day)
20.29%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2025 (TTM): S$56.23 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are S$0.71 Billion. In 2024 the company made an earning of -S$81.78 Million a decrease over its 2023 earnings that were of S$79.95 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$56.23 M-168.76%
2024 -S$81.78 Million-202.28%
2023 S$79.95 M363.85%
2022 S$17.23 M-76.42%
2021 S$73.09 M180.76%
2020 S$26.03 M-286.92%
2019 -S$13.93 Million2428.94%
2018 -S$0.56 Million-99%
2017 -S$55.04 Million12.23%
2016 -S$49.05 Million-1885.05%
2015 S$2.74 M-115.65%
2014 -S$17.56 Million-78.95%
2013 -S$83.4 Million21.55%
2012 -S$68.61 Million41.18%
2011 -S$48.6 Million57.4%
2010 -S$30.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Recro Pharma
REPH
S$4.87 M-91.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion-289.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-S$81.38 Million-250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-S$17.6 Million-132.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-S$0.17 Billion-401.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-S$0.28 Billion-606.90%๐Ÿ‡บ๐Ÿ‡ธ USA